Finch Therapeutics | 10-K/A: Annual report (Amendment)
Apr 26 17:00 ET
Finch Therapeutics | 8-K: Current report
Apr 3 07:32 ET
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SMISEK JEFFERY A
Mar 29 16:19 ET
Finch Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 28 16:41 ET
Finch Therapeutics | 10-K: Annual report
Mar 25 16:36 ET
Finch Therapeutics | 8-K: Current report
Feb 23 16:16 ET
Finch Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Chidozie Ugwumba(9.99%)
Dec 13, 2023 17:20 ET
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SMISEK JEFFERY A
Nov 27, 2023 16:54 ET
Finch Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 22, 2023 16:37 ET
Finch Therapeutics | 8-K: Current report
Nov 17, 2023 16:30 ET
Finch Therapeutics: Q3 2023 Earnings Report
Nov 8, 2023 06:30 ET
Finch Therapeutics | 10-Q/A: Quarterly report (Amendment)
Aug 11, 2023 06:31 ET
Finch Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 10, 2023 06:31 ET
Finch Therapeutics | 8-K: Current report
Jul 7, 2023 16:30 ET
Finch Therapeutics | 8-K: Current report
Jun 28, 2023 16:31 ET
Finch Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Blischak Matthew P.
Jun 23, 2023 16:30 ET
Finch Therapeutics | 8-K: Current report
Jun 23, 2023 07:30 ET
Finch Therapeutics | 8-K: Current report
Jun 9, 2023 17:00 ET
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Blischak Matthew P.
Jun 9, 2023 16:52 ET
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lange Christian H.
Jun 9, 2023 16:22 ET
No Data
No Data